Effect of ranolazine on ventricular vulnerability and defibrillation threshold in the intact porcine heart

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 10, 2008, Pages 1073-1079

  Kumar, Kapil ^a   Nearing, Bruce D ^a   Bartoli, Carlo R ^a   Kwaku, Kevin F ^a   Belardinelli, Luiz ^b   Verrier, Richard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CV THERAPEUTICS INC   (United States)

Author keywords

Antiarrythmia agents; Death; Defibrillation; Electrical stimulation; Sudden; Tachyarrythmia

Indexed keywords

RANOLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE REFRACTORY PERIOD; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; SWINE;

ACETANILIDES; ANIMALS; DIFFERENTIAL THRESHOLD; ELECTRIC COUNTERSHOCK; ENZYME INHIBITORS; HEART CONDUCTION SYSTEM; PIPERAZINES; SWINE; VENTRICULAR FUNCTION, LEFT;

EID: 52149109259     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2008.01204.x     Document Type: Article

References (23)

1. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, Murphy SA, Budaj A, Varshavsky S, Wolff AA, Skene A, McCabe CH, Braunwald E MERLIN-TIMI 36 Trial Investigators: Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: The MERLIN-TIMI 36 randomized trial. JAMA 2007 297 : 1775 1783.
2. Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM, Cordeiro JM, Thomas G : Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 2004 110 : 904 910.
3. Belardinelli L, Shryock JC, Fraser H : Inhibition of the late sodium current as a potential cardioprotective principle: Effects of the late sodium current inhibitor ranolazine. Heart 2006 92 (Suppl 4 iv6 iv14.
4. Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, Molhoek P, Verheugt FWA, Gersh BJ, McCabe CH, Braunwald E : Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non-ST-segment elevation and acute coronary syndrome. Results from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2007 116 : 1647 1652.
5. Topham SL, Cha YM, Peters BB, Chen PS : Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs. Circulation 1992 85 : 1146 1151.
6. Murakawa Y, Sezaki K, Inoue H, Usui M, Yamashita T, Ajiki K, Oikawa N, Iwasawa K, Omata M : Shock-induced refractory period extension and pharmacologic modulation of defibrillation threshold. J Cardiovasc Pharmacol 1994 23 : 822 825.
7. Wang M, Dorian P : DL and D sotalol decrease defibrillation energy requirements. Pacing Clin Electrophysiol 1989 12 : 1522 1529.
8. Xia Y, Liang Y, Kongstad O, Liao Q, Holm M, Olsson B, Yuan S : In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine. Heart Rhythm 2005 2 : 162 169.
9. Opthof T, Coronel R, Wilms-Schopman FJG, Plotnikov AN, Shlapakova IN, Danilo P, Rosen MR, Janse MJ : Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. Heart Rhythm 2007 4 : 341 348.
10. Matta RJ, Verrier RL, Lown B : Repetitive extrasystole as an index of vulnerability to ventricular fibrillation. Am J Physiol 1976 230 : 1469 1473.
11. Kowey PR, Verrier RL, Lown B : The repetitive extrasystole as an index of vulnerability to ventricular fibrillation during myocardial ischemia in the canine heart. Am Heart J 1983 106 : 1321 1325.
12. Zhao SX, Lee LM, Nearing BD, Busso VO, Kwaku KF, Verrier RL : Suppression of calcium-induced repolarization heterogeneity as a mechanism of nitroglycerin's antiarrhythmic action. J Cardiovasc Pharmacol 2006 48 : 22 29.
13. Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA : Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial. JAMA 2004 291 : 309 316.
14. Schram G, Zhang L, Derakhchan K, Ehrlich JR, Belardinelli L, Nattel S : Ranolazine: Ion-channel-blocking actions and in vivo electrophysiological effects. Br J Pharmacol 2004 142 : 1300 1308.
15. Undrovinas AI, Belardinelli L, Undrovinas NA, Sabbah HN : Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 2006 17 : S169 S177.
16. Gralinski MR, Black SC, Kilgore KS, Chou AY, McCormack JG, Lucchesi BR : Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Cardiovasc Res 1994 28 : 1231 1237.
17. Wu L, Shryock JC, Song Y, Li Y, Antzelevitch C, Belardinelli L : Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome. J Pharmacol Exp Ther 2004 310 : 599 605.
18. Chaitman BR : Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 2006 113 : 2462 2472.
19. Antzelevitch C, Belardinelli L : The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis. J Cardiovasc Electrophysiol 2006 17 : S79 S85.
20. Moore EN, Spear JF : Ventricular fibrillation threshold: Its physiological and pharmacological importance. Arch Intern Med 1975 135 : 446 453.
21. Kirchhof PF, Fabritz CL, Zabel M, Franz MR : The vulnerable period for low and high-energy T-wave shocks: Role of dispersion of repolarisation and effect of d-sotalol. Cardiovasc Res 1996 31 : 953 962.
22. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C : Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation. Differences in sodium channel inactivation between atria and ventricles and the role of ranolazine-selective sodium channel block as a novel strategy for the management of AF. Circulation 2007 116 : 1449 1457.
23. Rajamani S, Shryock JC, Belardinelli L : Mechanism of ranolazine block of cardiac Na channels (abstract). Eur Heart J 2007 28 : 400.